Search Page

1

Cite

Share

Az orvosi kódtárak gyakorlati alkalmazása az onkológiában – szakmai útmutató a Nemzeti Rákregiszter tapasztalatai alapján.

Kenessey I, Wéber A, Szilágyi I, Nagy P, Polgár C, Kásler M. Kenessey I, et al. Magy Onkol. 2022 Mar 28;66(1):4-10. Epub 2021 Dec 18. Magy Onkol. 2022. PMID: 35343969 Free article. Review. Hungarian.

Cite

Share

2

Cite

Share

[Pathology background of targeted therapy; quality control in pathology].

Kulka J, Szirtes I, Szász AM, Kupcsulik P, Kenessey I, Lotz G, Tímár J. Kulka J, et al. Among authors: kenessey i. Magy Onkol. 2010 Dec;54(4):343-50. doi: 10.1556/MOnkol.54.2010.4.8. Magy Onkol. 2010. PMID: 21163765 Free article. Hungarian.

Cite

Share

3

Cite

Share

Smoking, chromosomal aberrations, and cancer incidence in healthy subjects.

Farkas G, Kocsis ZS, Székely G, Dobozi M, Kenessey I, Polgár C, Jurányi Z. Farkas G, et al. Among authors: kenessey i. Mutat Res Genet Toxicol Environ Mutagen. 2021 Jul;867:503373. doi: 10.1016/j.mrgentox.2021.503373. Epub 2021 Jun 18. Mutat Res Genet Toxicol Environ Mutagen. 2021. PMID: 34266629 Free article.

Cite

Share

4

Cite

Share

Preventing cancer therapy-related heart failure: the need for novel studies.

Fogarassy G, Vathy-Fogarassy Á, Kenessey I, Veress G, Polgár C, Forster T. Fogarassy G, et al. Among authors: kenessey i. J Cardiovasc Med (Hagerstown). 2021 Jun 1;22(6):459-468. doi: 10.2459/JCM.0000000000001115. J Cardiovasc Med (Hagerstown). 2021. PMID: 32941327

Cite

Share

5

Cite

Share

[Consequences of extracellular alterations of EGFR on cetuximab therapy in HNSCC].

Cserepes M, Nelhűbel GA, Meilinger-Dobra M, Surguta SE, Rásó E, Ladányi A, Kenessey I, Szöőr Á, Vereb G, Remenár É, Tóvári J. Cserepes M, et al. Among authors: kenessey i. Magy Onkol. 2021 Jun 3;65(2):188-195. Epub 2021 May 12. Magy Onkol. 2021. PMID: 34081766 Free article. Hungarian.

Cite

Share

6

Cite

Share

[Study of drugs against neoplastic metastasis].

Jeney A, Kenessey I, Timár F, Oláh J, Pogány G, Babó I, Harisi R. Jeney A, et al. Among authors: kenessey i. Magy Onkol. 2006;50(2):93-100. Epub 2006 Aug 4. Magy Onkol. 2006. PMID: 16888671 Free article. Review. Hungarian.

Cite

Share

7

Cite

Share

[EGFR protein is a negative prognostic and predictive factor in wild-type RAS colorectal cancer].

Uhlyarik A, Piurkó V, Pápai Z, Rásó E, Lahm E, Kiss E, Sikter M, Vachaja J, Vízkeleti L, Kenessey I, Tímár J. Uhlyarik A, et al. Among authors: kenessey i. Magy Onkol. 2021 Jun 3;65(2):121-127. Epub 2021 May 16. Magy Onkol. 2021. PMID: 34081760 Free article. Hungarian.

Cite

Share

8

Cite

Share

Isoprostanes evoke contraction of the murine and human detrusor muscle via activation of the thromboxane prostanoid TP receptor and Rho kinase.

Molnár PJ, Dér B, Borsodi K, Balla H, Borbás Z, Molnár K, Ruisanchez É, Kenessey I, Horváth A, Keszthelyi A, Majoros A, Nyirády P, Offermanns S, Benyó Z. Molnár PJ, et al. Among authors: kenessey i. Am J Physiol Renal Physiol. 2021 Apr 1;320(4):F537-F547. doi: 10.1152/ajprenal.00400.2020. Epub 2021 Jan 25. Am J Physiol Renal Physiol. 2021. PMID: 33491563 Free article. Review.

Cite

Share

9

Cite

Share

Molecular interactions between poly(ADP-ribose) polymerase (PARP I) and topoisomerase I (Topo I): identification of topology of binding.

Bauer PI, Chen HJ, Kenesi E, Kenessey I, Buki KG, Kirsten E, Hakam A, Hwang JI, Kun E. Bauer PI, et al. Among authors: kenessey i. FEBS Lett. 2001 Oct 12;506(3):239-42. doi: 10.1016/s0014-5793(01)02919-2. FEBS Lett. 2001. PMID: 11602253 Free article.

Cite

Share

10

Cite

Share

Prognostic impact of CD73 expression and its relationship to PD-L1 in patients with radically treated pancreatic cancer.

Tahkola K, Ahtiainen M, Kellokumpu I, Mecklin JP, Laukkarinen J, Laakkonen J, Kenessey I, Jalkanen S, Salmi M, Böhm J. Tahkola K, et al. Among authors: kenessey i. Virchows Arch. 2021 Feb;478(2):209-217. doi: 10.1007/s00428-020-02888-4. Epub 2020 Jul 16. Virchows Arch. 2021. PMID: 32676968 Free PMC article.

Cite

Share